PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
8101430-3	1993	PACAP-stimulated release of PYY was inhibited significantly by atropine, whereas ganglionic or beta-adrenergic blockade with hexamethonium and propranolol treatment, respectively, did not affect PACAP-induced release of PYY significantly (P > 0.05).	Atropine	63-71	peptide YY	Canis lupus familiaris	28-31	
8278624-3	1993	Atropine, hexamethonium and atropine plus hexamethonium treatment blocked food-induced release of PYY significantly.	Atropine	0-8	peptide YY	Canis lupus familiaris	98-101	
8278624-3	1993	Atropine, hexamethonium and atropine plus hexamethonium treatment blocked food-induced release of PYY significantly.	Atropine	28-36	peptide YY	Canis lupus familiaris	98-101	
8278624-4	1993	Integrated release of PYY in response to food alone and in combination with atropine, hexamethonium and atropine plus hexamethonium were 8.8 +/- 2.2, -1.1 +/- 2.3, -2.7 +/- 2.2 and -3.2 +/- 3.1 (ng (0-150) min/ml), respectively.	Atropine	76-84	peptide YY	Canis lupus familiaris	22-25	
8278624-4	1993	Integrated release of PYY in response to food alone and in combination with atropine, hexamethonium and atropine plus hexamethonium were 8.8 +/- 2.2, -1.1 +/- 2.3, -2.7 +/- 2.2 and -3.2 +/- 3.1 (ng (0-150) min/ml), respectively.	Atropine	104-112	peptide YY	Canis lupus familiaris	22-25	
8278624-8	1993	Together, these data suggest that food-stimulated PYY secretion is dependent on ganglionic transmission and an atropine-blockable postganglionic parasympathetic pathway; and that PYY release is inhibited tonically, probably through a vagal cholinergic mechanism.	Atropine	111-119	peptide YY	Canis lupus familiaris	50-53	
8134298-4	1993	A combination of atropine and hexamethonium eliminated the PYY-induced decrement in VIP output and left motor excitation unchanged.	Atropine	17-25	peptide YY	Canis lupus familiaris	59-62	
14687704-0	2004	Release of peptide YY by fat in the proximal but not distal gut depends on an atropine-sensitive cholinergic pathway.	Atropine	78-86	peptide YY	Canis lupus familiaris	11-21	
14687704-4	2004	We found that, when fat was confined to the proximal 1/2 of the intestine, PYY release was reduced following intravenous atropine when compared with saline (p<0.01).	Atropine	121-129	peptide YY	Canis lupus familiaris	75-78	
14687704-6	2004	We conclude that PYY release by fat in the proximal but not distal intestine depends on an atropine-sensitive, cholinergic pathway.	Atropine	91-99	peptide YY	Canis lupus familiaris	17-20	
1928591-8	1991	Pretreatment with atropine abolished the luminal PYY response to OGTT, and 2-DG did not affect luminal PYY recovery.	Atropine	18-26	peptide YY	Canis lupus familiaris	49-52	
8093875-4	1993	Intracolonic infusion of a mixture of tryptophan and phenylalanine (Trp+Phe; 100 mM; 200 ml/h) resulted in a significant release of PYY [integrated PYY release, 74.5 +/- 14.0 ng (0-120 min)/ml], which was not affected by iv atropine, hexamethonium, or propranolol treatment.	Atropine	224-232	peptide YY	Canis lupus familiaris	132-135	
1547726-7	1992	Electrical vagal stimulation of dogs resulted in a significant (P less than 0.05) release of PYY and PP, which was abolished by atropine treatment (2 mg/kg, iv).	Atropine	128-136	peptide YY	Canis lupus familiaris	93-96	
2888314-20	1987	Furthermore, PYY inhibit pentagastrin-stimulated gastric acid secretion in the face of atropine, vagotomy, or indomethacin treatment.	Atropine	87-95	peptide YY	Canis lupus familiaris	13-16	
2895586-8	1988	The inhibitory action of PYY on 2-DG-stimulated insulin release persisted in the presence of atropine or phentolamine treatment; however, hexamethonium alone or phentolamine plus propranolol treatment blocked the inhibitory action of PYY.	Atropine	93-101	peptide YY	Canis lupus familiaris	25-28